Avalo Therapeutics, Inc. ($AVTX)
Doyle Mittie โ Chief Medical Officer
Shares
105,000
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Doyle Mittie |
|---|---|
| Title | Chief Medical Officer |
| Transaction Date | Feb 26, 2026 |
| Expiration Date | Feb 26, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Stock Option (Right to Buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Mar 2, 2026 |
| Shares Purchased | 105,000 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 105,000 |
| Derivative | Derivative |
| Accession Number | 0001918845-26-000002 |
| Document | View SEC Filing |